Evidence map›Paper›PMID 36936745›Full record

ArticleAJP reports2023

A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites.

Kana Fukui, Shoichiro Amari, Nobuyuki Yotani, Rika Kosaki, Kenichiro Hata, Motomichi Kosuga, Haruhiko Sago, Tetsuya Isayama, Yushi Ito

Open access · goldAbstract readCase Reports
In one paragraph

Article in AJP reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Octreotide and direct/indirect lung injury.Research in pharmaceutical sciences · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kana FukuiDivision of Neonatology, National Center for Child Health and Development, Tokyo, Japan.ORCID 0000-0003-4834-5799
Shoichiro AmariDivision of Neonatology, National Center for Child Health and Development, Tokyo, Japan.
Nobuyuki YotaniDivision of Palliative Medicine, National Center for Child Health and Development, Tokyo, Japan.
Rika KosakiDivision of Medical Genetics, National Center for Child Health and Development, Tokyo, Japan.
Kenichiro HataDepartment of Maternal-Fetal Biology, National Center for Child Health and Development, Tokyo, Japan.
Motomichi KosugaDivision of Medical Genetics, National Center for Child Health and Development, Tokyo, Japan.
Haruhiko SagoCenter for Maternal-Fetal, Neonatal, and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
Tetsuya IsayamaDivision of Neonatology, National Center for Child Health and Development, Tokyo, Japan.
Yushi ItoDivision of Neonatology, National Center for Child Health and Development, Tokyo, Japan.
National Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a patient with severe fetal hydrops and refractory ascites, diagnosed as mucopolysaccharidosis type VII (MPS VII) by whole-exome sequencing, and discharged at 5 months of age after long-term ventilatory management. A male neonate was born by emergency cesarean section due to fetal distress at 30

Indexed as

fetal hydropsGUSB geneMPS VIIrefractory ascites

Identifiers

PMID36936745
PMCPMC10019997
OpenAlexW4319301226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.